ID

33873

Descripción

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Palabras clave

Versiones (1)
  1. 4/1/19 4/1/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

4 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Inglés

Non-Serious Adverse Events

1 formularios  
Non-Serious Adverse Events
Descripción

Non-Serious Adverse Events

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Descripción

Non-Serious Adverse Event, Administration of vaccine, Post

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C2368628
UMLS CUI [1,3]
C0687676
Adverse Event No.
Descripción

Non-Serious Adverse Event, Numbers

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
Description
Descripción

Non-Serious Adverse Event, Description

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0678257
Description
Descripción

Non-Serious Adverse Event, Description

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0678257
Date Started
Descripción

Non-Serious Adverse Event, Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0808070
Started during immediate post-vaccination period specified in protocol
Descripción

Non-Serious Adverse Event, Start, Vaccination; Post

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C0042196
UMLS CUI [1,4]
C0687676
Date Stopped
Descripción

Non-Serious Adverse Event, End Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0806020
Intensity
Descripción

Non-Serious Adverse Event, Intensity

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0806020
Causality In your opinion, did the vaccine possibly contribute to this AE?
Descripción

Non-Serious Adverse Event, Causality, Vaccines

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C1314792
UMLS CUI [1,3]
C0042210
Outcome
Descripción

Non-Serious Adverse Event, Adverse Event Outcome

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C1705586
Volver a la parte superior de la página

Similar models

Non-Serious Adverse Events

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Non-Serious Adverse Events
C1518404 (UMLS CUI-1)
Non-Serious Adverse Event, Administration of vaccine, Post
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1519255 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
Item
Adverse Event No.
text
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Non-Serious Adverse Event, Numbers
Code List
Adverse Event No.
CL Item
AE. 1 (AE. 1)
CL Item
AE. 2 (AE. 2)
CL Item
AE. 3 (AE. 3)
CL Item
AE. 4 (AE. 4)
CL Item
AE. 5 (AE. 5)
CL Item
AE. 6 (AE. 6)
Non-Serious Adverse Event, Description
Item
Description
text
C1518404 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Item
Description
text
C1518404 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Non-Serious Adverse Event, Description
Code List
Description
CL Item
Local (injection sites) (Local (injection sites))
CL Item
™General (non injection site) (™General (non injection site))
Non-Serious Adverse Event, Start Date
Item
Date Started
date
C1518404 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Non-Serious Adverse Event, Start, Vaccination; Post
Item
Started during immediate post-vaccination period specified in protocol
boolean
C1518404 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
Non-Serious Adverse Event, End Date
Item
Date Stopped
date
C1518404 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Intensity
text
C1518404 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Non-Serious Adverse Event, Intensity
Code List
Intensity
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
Non-Serious Adverse Event, Causality, Vaccines
Item
Causality In your opinion, did the vaccine possibly contribute to this AE?
boolean
C1518404 (UMLS CUI [1,1])
C1314792 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Item
Outcome
text
C1518404 (UMLS CUI [1,1])
C1705586 (UMLS CUI [1,2])
Non-Serious Adverse Event, Adverse Event Outcome
Code List
Outcome
CL Item
Recovered (™1)
CL Item
Recovered with sequelae (™2)
CL Item
Ongoing at subject study conclusion (™3)
CL Item
Died (™4)
CL Item
Unknown (™5)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial